Meng 2017. The Doublesex-related Dmrta2 safeguards neural progenitor maintenance involving transcriptional regulation of Hes1.
Introduction
Balancing neural progenitor cell (NPC) self-renewal and neuronal differentiation is essential for generating cells in correct numbers and diverse types during brain development (1, 2) . As such, cortical neurogenesis is tightly regulated by a complex array of transcription factors that work in concert to coordinate NPC maintenance and differentiation. Proneural transcription factors, such as neurogenin (Neurog) and Neurod, act as the primary initiators of differentiation through their direct regulation of target genes associated with cytoskeletal reorganisation, migration and other critical differentiation processes (3, 4) . Proneural transcription factors are themselves subject to transcriptional regulation by other cortical transcription factors such as Pax6 and Hes1. Pax6 acts upstream to promote neuronal differentiation through its direct activation of proneural genes (5) . On the other hand, the basic helix-loop-helix transcription factor Hes1 promotes NPC proliferation and self-renewal through its repressive actions on proneural gene expression, thereby restricting spontaneous differentiation (6) . Significant disruptions to this delicate regulatory network can result in severe developmental defects due to altered neuronal production (1, 2) . One such disorder is microlissencephaly, a rare genetic-linked group of neurodevelopmental malformations characterised by the absence of sulci and gyri of the cerebral cortex and an accompanying reduction in cortical size and volume. Recently, a loss-of-function mutation in the Doublesexand Mab-3-related transcription factor A2 (DMRTA2, also known as DMRT5) gene has been reported in a case of microlissencephaly, implicating DMRTA2 as a critical regulator of cortical NPC dynamics (7) .
Dmrta2 belongs to the highly conserved family of Dmrt transcription factors whose roles in the developing reproductive system have been extensively characterised (8) . However, a further site of expression and function of Dmrta2 has been found in the embryonic brain (9, 10) . Dmrta2 loss-of-function in Zebrafish leads to significant reductions in cortical size, coupled with reduced neuronal numbers (10, 11) . Likewise, a smaller neocortex, particularly dorsomedial neocortex, has been observed in mice carrying null deletions of Dmrta2 (12) (13) (14) . Together with the association of DMRTA2 mutation and microlissencephaly in humans, these findings implicate Dmrta2 as an important regulator for cortical neurogenesis. However, Dmrta2-null mice additionally present agenesis of the embryonic cortical hem. The cortical hem is the embryonic organizer for the hippocampus and a major regulator of cortical patterning outside the hippocampus. It provides a source of Wingless-related (WNT) and bone morphogenetic protein (BMP) signalling in the dorsomedial telencephalon to control proper cortical regionalisation and NPC expansion in a paracrine fashion (15, 16) . Thus, the severe patterning and arealisation defects in Dmrta2-null model organisms prohibit a clear dissection between a direct role of Dmrta2 in NPC behaviour from the secondary effect of an overall reduction in extrinsic hem-derived signals. More recently, conditional Dmrta2 mutant mice (Dmrta2 fl/fl ;Emx1-cre), that delete Dmrta2 in cortical progenitors after cortical hem formation, also have reduced cortical hemisphere size suggesting a direct role of Dmrta2 in the control of NPC behaviour, which remains to be defined (14) .
Embryonic stem cells (ESCs) are capable of giving rise to all somatic cell types with easy access during in vitro differentiation. Mouse and human ESCs can efficiently generate cortical NPCs in culture without any added morphogens and subsequently differentiated into layer-specific neurons in a temporally regulated fashion recapitulating major steps of normal cortical development (17) (18) (19) . In this study, we analysed the behaviour of mouse ESCderived cortical progenitors either lacking Dmrta2 or conditionally expressing transgenic Dmrta2 (9) . We report that enforced expression of Dmrta2 in cortical NPCs suppresses neuronal differentiation without affecting neurogenic competence, while in its absence cortical NPCs undergo precocious cell cycle exit and neuronal differentiation in vitro and in vivo. We provide evidence that Dmrta2 maintains NPC status via transcriptional regulation of Hes1. Thus, this study identifies a new layer of genetic control by Dmrta2 in fine tuning cortical NPC proliferation and terminal differentiation.
Results

Expression of Dmrta2 by ESC-derived cortical NPCs
In order to achieve efficient induction of cortical fate from mouse ESCs, we incorporated in our protocol several measures previously shown to promote a dorsal telencephalic fate ( Fig.  1A ) (17) . These included dual SMAD inhibition with SB431542 and LDN193189 to accelerate neural induction (20) , the addition of a Wnt inhibitor XAV to suppress caudalization (21, 22) , and cyclopamine to antagonise ventralisation of neural progenitor cells by endogenous sonic hedgehog (SHH) signalling (cultures generated by this paradigm are referred to hereafter as cortical cultures) (18) . As negative controls for cortical identity, we in parallel induced ESCs towards a ventral telencephalic fate with SHH, a caudal fate with retinoic acid, and a ventral mesencephalic (dopaminergic) fate using a combinatorial treatment of ERK inhibitor and SHH ( Fig S1A) (23) . The generation of cortical NPCs was verified by immunostaining at day 6-8 for cortical specific or cortical enriched markers Pax6, Lmx1a, Eomes (Tbr2), Otx2, Coup-TF1 and FORSE-1 (also known as LeX) along with nestin as a pan NPC marker ( Fig. 1B and C, Fig. S1B and D). The vast majority of cells in the cortical cultures stained positive for Pax6, FORSE-1, Otx2, Lmx1a, Coup-TF1 and nestin, while a proportion of cells also expressed Eomes. The transcription factor Nkx2.1 is specifically expressed by medial ganglionic eminence progenitors. While abundant Nkx2.1 + cells were detected in SHH treated ventral telencephalic cultures, negligible numbers of Nkx2.1 + cells were found in cortical cultures ( Fig. S1B ). Foxa2 is a marker for the ventral midbrain and spinal cord. Few Foxa2 + cells were observed in the cortical cultures while they constituted the major population in dopaminergic differentiated cultures ( Fig. S1C ).
Double immunocytochemistry showed that Dmrta2 + cells were confined to Nestin + and FORSE-1 + NPCs in cortical cultures, representing 30-54% of the total cell population between day 4-10 ( Fig. 1B and D) . During development, Dmrta2 expression is restricted to the dorsal telencephalon where it is co-expressed with Pax6 but in an opposite gradient (12, 13, 24) . Consistent with its expression in vivo, we found that Dmrta2 and Pax6 staining largely overlapped in ESC-derived NPCs localized in neural rosettes, from which Eomes + basal progenitor cells could be seen extending distally (Fig. 1C ). In contrast, no Dmrta2 + cells were found in SHH-or retinoic acid-treated neural progenitor cultures ( Fig S1B and D) .
Dmrta2 + cells were no longer detectable by day 15 of differentiation. At this stage, the presence of postmitotic cortical neurons was confirmed by immunostaining for cortical layerspecific neuronal markers Tbr1 (layer VI), Bcl11b (Ctip2 (layer V and VI)), and Satb2 (layer II/III) and a pan-glutamatergic neuronal marker vGlut1 ( Fig. 1E and F, Fig. S1E ). Very few GABAergic neurons, identified by GAD65/67 immunostaining, were observed in the cortical cultures ( Fig. S1E ). Moreover, we did not observe TH + /Nurr1 + dopaminergic neurons or Isl1 + /Olig2 + spinal motor neurons, confirming an enrichment of cortical neurons in our cultures ( Fig S1F and G) . Together, our data demonstrates the ability to reproduce in vitro Dmrta2 + dorsal telencephalic NPCs and their neuronal progeny.
Enforced expression of Dmrta2 suppresses NPC neuronal differentiation
To investigate a role for Dmrta2 in telencephalic NPC behaviour, we firstly examined the effect of Dmrta2 gain of function in neuronal differentiation of ESC-derived NPCs using a tetracycline-inducible Dmrta2 transgenic mESC model (Dmrta2-ESCs) reported previously (9) . These cells harbour the reverse tetracycline-controlled transactivator (rtTA) and produce significant levels of Dmrta2 protein in response to the addition of doxycycline to the culture media. Dmrta2 transgene was induced at the peak of NPC production for 7 days from day 5 and the expression of several neurogenic genes examined by qPCR ( Fig. 2A and B) . In the control condition, without doxycycline, the level of proneural gene transcripts (Neurog2, Neurod1 and Neurod4) increased gradually from day 6, along with the immature neuronal marker gene Tubb3 (β3-tubulin). However, lower levels of all these transcripts were detected in parallel sister cultures treated with doxycycline at all timepoints analysed. In contrast, the transcript levels of Hes1, a repressor of cortical neurogenesis, was robustly upregulated (Fig. 2B ). These gene expression changes were concurrent with the induced transgenic Dmrta2 from day 6, which remained at a higher level than in control cultures throughout.
Consistent with the qPCR observations, cells exposed to doxycycline for 5 days maintained a largely NPC morphology while the sister control cells progressed to terminal differentiation into neurons ( Fig. 2C ). Immunostaining confirmed a marked reduction of Tubb3 + cells in doxycycline treated cultures compared to controls. In contrast, doxycycline-treated cultures contained more Nestin + NPCs (Fig. 2D ). Moreover, double immunocytochemistry for Dmrta2 and Tubb3 revealed mutually exclusive staining in doxycycline-treated cultures, providing direct evidence that a high level of Dmrta2 suppresses neuronal differentiation of NPCs ( Fig.  2E ).
Interestingly, upon removal of doxycycline after 4 days treatment, the NPCs readily gave rise to Tubb3 + neurons ( Fig. S2 ). This finding suggests that a high level of Dmrta2 favours NPC maintenance over neuronal differentiation without affecting their neurogenic competence.
Loss of Dmrta2 accelerates neuronal differentiation of cortical NPCs
To gain further insights into the physiological function of Dmrta2 in neurogenesis and the cellular mechanisms that might underpin microcephaly caused by Dmrta2 loss-of-function mutation, we generated lines of mESCs with homozygous deletion of Dmrta2 (Dmrta2 -/-) by gene targeting and directed these cells towards cortical fate ( Fig. 3 and Fig. S3 ). We closely monitored neural induction and neuronal differentiation in Dmrta2 -/and isogenic control (Dmrta2 flox/flox ) cultures by immunocytochemistry and qPCR ( Fig. 3A and B) . Rapid neuroepithelial fate conversion was observed in both genotypes as demonstrated by the generation of a similar proportion of Nestin + NPCs at day 4 and day 6 ( Fig. 3A ). However, following the onset of Dmrta2 expression at day 4, we observed marked differences in the temporal expression profile of the intermediate progenitor marker gene Eomes, neuronal marker Map2, and proneural transcription factors Neurog2 and Neurod1 (Fig. 3B ). Map2 and Eomes levels were increased in the Dmrta2 -/cultures while both Neurog2 and Neurod1 RNA reached their highest levels sooner in Dmrta2 -/cells than the control cells, suggesting an early initiation of neurogenesis programme. Consistent with this observation, we detected an increase in the production of Tubb3 + neurons in Dmrta2 -/cultures by immunostaining at days 4, 6 and 8 compared to the isogenic control cultures (Fig. 3C) . Similarly, Dmrta2 -/cultures also contained significantly more NeuN + cells (mature neurons) at days 10 to 14 (Fig. 3D ).
In the reduced cortex of Dmrta2 -/embryos, a transient increase in neuronal production has also been observed during early corticogenesis. This excess of neuronal production during early neurogenesis may be a secondary consequence of the reduction of Wnt cortical hem signals or a direct consequence of the loss of Dmrta2 in cortical progenitors (12) . To test this latter possibility, we assessed by immunostaining the amount of Tubb3 + and Eomes + cells in the cortical plate of E11 conditional Dmrta2 mutant mice (Dmrta2 fl/fl ;Emx1-cre) in which Wnt signalling pathway appears unaffected (14) . An increase of Tubb3 + and of Eomes + cells was found in the conditional Dmrta2 mutant mice relative to controls ( Fig. 4 ). Thus, premature neuronal differentiation is also a feature in vivo of conditional Dmrta2 mutant mice, corroborating the in vitro observations and suggesting a direct role for Dmrta2 in cortical NPC neurogenesis.
Altered Dmrta2 levels leads to cell cycle dysregulation in cortical NPCs
Disrupted cortical NPC proliferation and cell cycle progression has been implicated as an underlying mechanism for microlissencephaly (25) . To determine whether Dmrta2 plays a role in cell cycle regulation, we performed a flow cytometry-based cell cycle analysis to reveal the distribution of Nestin + NPCs in three major phases of the cell cycle (G0/1, S and G2/M) ( Fig. 5A ). Significantly more Dmrta2 -/cortical NPCs were found in G0/1 phase (p<0.01) than the control cells at day 6 of differentiation ( Fig. 5B) . Accordingly, the number of cells in the S phase was reduced (p<0.05) in day 6 Dmrta2 -/-NPCs compared to controls, although no differences were found on days 8 and 10.
To gain further insight into Dmrta2-regulated cell cycle progression, we carried out EdU incorporation assays at days 6, 8 and 10 of differentiation. This study revealed a reduction in the number of EdU-labelled cells in Dmrta2 -/cultures compared to control cultures at all three time points, providing independent evidence of altered S phase in Dmrta2 -/-NPCs ( Fig.  5C ). Moreover, immunocytochemical analysis showed that cells expressing Cdkn1b (p27kip1) and Cdkn1c (p57Kip2) are both increased in Dmrta2 -/cultures compared to controls ( Fig. 5C ). Cdkn1b and Cdkn1c are cell cycle regulators with a major function to halt or slow the G1-S phase transition and hence their upregulation is closely associated with cell cycle exit and neuronal differentiation. In contrast, we observed a reduction at the transcript level of these two cell cycle regulators and an increase in the proportion of Ki67 + cells when NPCs were forced to express Dmrta2 (Fig. S4 ). Together, these findings identify a new role for Dmrta2 in NPC cell cycle regulation and suggest that the disrupted regulation of cell cycle progression in Dmrta2 -/-NPCs may be a significant contributory factor to the precocious neurogenesis described above.
Genome-wide transcriptome profiling supports a role for Dmrta2 in NPC neurogenesis
In order to gain insight into the molecular mechanisms underlying the altered neurogenesis in Dmrta2-deficient NPCs, we carried out a transcriptome analysis by RNA sequencing (RNAseq) using day 8 cultures, a timepoint associated with the highest number of Dmrta2 + cells and when both neurogenic and proliferative defects were apparent. Analysis of this RNAseq dataset identified 7343 differentially expressed transcripts at a significance level of p<0.05 ( Fig. 6A, Fig. S5 and Dataset S1). Amongst the Dmrta2-regulated genes were a number of transcription factors involved in cortical development and patterning, including Foxg1, Pax6, Emx1, Emx2, Nr2f1 (Coup-TF1) and Sp8 ( Fig. 6B and C) . Similarly, genes associated with development of the cortical hem, Lmx1a and Msx1, were significantly downregulated in Dmrta2 -/cultures. Interestingly, Dmrta2 itself was identified as one of the most significantly upregulated transcripts upon loss of Dmrta2 ( Fig. 6B and Fig. S5C ). The closely-related Dmrt family member Dmrta1 was also upregulated in Dmrta2 -/-NPCs, while no significant change was found for Dmrt3. In the reduced cortex of Dmrta2 conditional mutants, Dmrta2 and Dmrta1 have been also found to be upregulated (14) . Together, these observations further support a negative autoregulatory function for Dmrta2, as well as regulatory interactions with other Dmrt family members.
We are particularly interested in genes and gene-sets that have a functional role in NPC proliferation and/or neuronal differentiation. Our data revealed a significant downregulation of Hes1 (Fig. 6C ). Downregulated expression was also identified for other transcription factors known to complex with Hes1 to repress proneural gene expression and promote NPC proliferation, including Id1, Id3 and Tcf3 (6, 26, 27) . In contrast, we found an upregulation in the expression of Hes1 target proneural genes Neurog1, Neurog2 and Ascl1, together with their downstream target genes Neurod1, Neurod4 and Nhlh1 (3, 4) .
Furthermore, genes known to perform opposing actions to Hes1 by promoting the expression of proneural genes were upregulated, including Pax6 and Btg2 (5, 28) . Other upregulated transcription factors with pro-neuronal functions included Insm1, Myt1l and Brn2 (29, 30) . Consistent with these findings, molecular markers for intermediate progenitor (Eomes), immature (Dcx) and mature (Mapt, Nefh and Rbfox3) neurons were also upregulated in Dmrta2 -/cells ( Fig. 6D ).
To provide a broader overview of the cellular functions played by Dmrta2-regulated genes/gene-sets, we performed a gene ontology functional enrichment analysis using gene lists meeting the stringent criteria of p<0.01 and an absolute fold change value greater than two. This analysis revealed that the 650 upregulated genes meeting these criteria are enriched in transcripts associated with biological processes including neuronal differentiation, neurogenesis and nervous system development in general ( Fig. S5A ). Similarly, enrichments for genes linked to the regulation of cell proliferation, organ morphogenesis and locomotion were identified in 936 transcripts downregulated in Dmrta2 -/cortical NPCs (Fig. S5B ). Together, our global gene expression analysis provides strong independent support that Dmrta2 plays a role in balancing NPC proliferation and neurogenesis.
Dmrta2-controlled neuronal differentiation involves direct regulation of Hes1
The significant downregulation of Hes1 revealed by the RNAseq analysis in addition to its robust induction in response to Dmrta2 transgene expression in NPCs suggests that Dmrta2 may maintain cortical NPC status via regulating Hes1 transcription. To determine whether this is mediated by direct binding of Dmrta2, we performed chromatin immunoprecipitation (ChIP) on day 8 Dmrta2 flox/flox NPCs, with Dmrta2 -/-NPCs serving as a negative control. Based on the published consensus binding sequence for Dmrta2, we identified three potential binding sites (Bs1-3) at the Hes1 locus ( Fig. 7A) (31) . Dmrta2-immunoprecipitation of DNA fragments at each of these sites was quantified relative to a non-bound control region (NBCR) by qPCR ( Fig. 7B ). An enrichment in Dmrta2-bound fragments was identified at binding sites Bs1 and Bs2 (p<0.05) but not in Bs3 in Dmrta2 flox/flox cells. In contrast, no enrichment was detected at any of the three potential binding sites in Dmrta2 -/negative control cells. Thus, Dmrta2 binds to the Hes1 gene in NPCs.
To provide evidence for Dmrta2 regulatory activity at Bs1 and Bs2, we performed reporter assays using a Hes1 promoter-driven luciferase vector (32) . A two-fold higher basal Hes1 promoter activity level was recorded in the isogenic Dmrta2 flox/flox cultures relative to the Dmrta2 -/-NPCs on day 8 of differentiation (p<0.001) ( Fig. 7C ). An A>C point mutation at position -3 of the binding motif has been shown to significantly impair the ability of Dmrta2 to bind to its target sequence (31) . We therefore introduced A>C point mutations at Bs1 and Bs2 by site-directed mutagenesis to yield two mutated reporter constructs, pHes1-luc-Bs1g.2007A>C and pHes1-luc-Bs2g.2365A>C, respectively. The mutation at Bs1, but not Bs2, resulted in a significant reduction of elevated Hes1 promoter activity levels in Dmrta2 flox/flox NPCs relative to the parental luciferase construct (p<0.01), suggesting reduced binding of Dmrta2 to the mutated Bs1 ( Fig. 7C ). Together these data strongly support the ability of Dmrta2 to bind to and regulate transcriptional activity at Bs1 on the Hes1 genomic locus.
We next sought to determine the extent to which reduced Hes1 expression in Dmrta2 -/-NPCs may contribute to their altered neurogenesis. To this end, Dmrta2 flox/flox and Dmrta2 -/-NPCs were transfected with a Hes1-expression vector on day 6 of differentiation together with a GFP-coding plasmid to distinguish between Hes1-transfected and non-transfected cells (Fig. 7D ). By quantifying Tubb3 staining 48 hours post-transfection, we identified significantly increased numbers of neurons in the non-transfected population of Dmrta2 -/cells relative to non-transfected isogenic controls (p<0.01). As predicted based on known Hes1 function, Hes1 transgene expression led to a reduction in neuronal production for each cell line. Interestingly, no significant differences between cell lines were identified within the Hes1 transfected populations. Thus, Hes1 trangene expression leads to a rescue of the precocious neurogenesis associated with the loss of Dmrta2.
We then asked whether siRNA-mediated knockdown of Hes1 expression could attenuate the anti-neurogenic effect of Dmrta2 transgenic expression in cortical NPCs. Dmrta2-ESCs were treated with doxycycline and Hes1-siRNA or a control non-targeting siRNA from day 5 to 12 of differentiation. Hes1-knockdown resulted in a significant reduction of Nestin + NPCs (p<0.05) and concurrent increase in the proportion of Tubb3 + neuronal cells ( Fig. 7E ). Thus, Hes1 knockdown partially reverses Dmrta2-mediated suppression of neuronal differentiation.
Together, our data identify Hes1 as a downstream target of Dmrta2 transcriptional regulation and a mechanism through which Dmrta2 safeguards NPCs from premature differentiation.
Discussion
Dmrta2 in NPC cell cycle regulation
Loss-of-function mutations in Dmrta2 have been linked with microcephaly in zebrafish, mice and humans (7, (10) (11) (12) (13) . However, the role and mechanism of action of Dmrta2 in the control of NPC maintenance and expansion remains, until now, completely unknown. Recently, conditional Dmrta2 mutant mice (Dmrta2 fl/fl ;Emx1-cre) have been created that delete Dmrta2 in cortical progenitors after cortical hem formation without impacting Wnt signalling. The Dmrta2 cKO embryos also show reduced cortical hemisphere size suggesting a direct role of Dmrta2 in the control of NPC behaviour (14) . Cells in a monolayer ESC-neural differentiation system are by and large exposed to the same extracellular environment and don't form 'signalling centres' as those found in the developing brain. Moreover, daily changes of culture media will reduce the impact of any secreted molecules that may elicit a secondary effect. Our pathway analysis of the RNAseq data did not reveal any significant changes in Wnt signalling, therefore, the observed effect of Dmrta2 on cell cycle changes is likely cell autonomous.
In line with the accumulation of Dmrta2 -/-NPCs in the G0/G1 phase of the cell cycle, our study reported the altered expression of a number of cell cycle regulatory genes, particularly those acting on the G1 to S phase transition (Cdkn1b, Cdkn1c and Btg2). Together, these data suggest a disruption in cell cycle progression and potential lengthening of the G1 phase in Dmrta2 -/-NPCs. During normal corticogenesis the duration of the G1 phase is linked to neuronal differentiation and is always higher in cells committed to undergo differentiative rather than proliferative divisions (33, 34) . Furthermore, experimental lengthening of the G1 phase pharmacologically or by the induction of Cdkn1b or Cdkn1c expression promotes neuronal differentiation and depletion of the NPC pool resulting in microcephaly (1, 33, 35) . The observed increase of Cdkn1b and Cdkn1c in Dmrta2 -/-NPCs strongly implicates delayed cell cycle progression of Dmrta2 -/-NPCs as a cellular mechanism contributing to precocious neurogenesis. However, it is unclear at present whether this is achieved through the direct regulation of cell cycle progression genes by Dmrta2. Although a number of G1-S transition regulatory molecules are known to act as downstream targets for Hes1 repression, Cdkn2c (p18ink4c) has also been identified as a candidate gene for direct Dmrta2-mediated regulation in the zebrafish testes (11, 36, 37) . Whether or not through a direct effect, our study demonstrates that Dmrta2 is intricately linked with the control of cell cycle progression, a feature conserved across species and tissues.
In addition to their function in the regulation of cell cycle progression, cyclin-dependent kinase inhibitors, including Cdkn1b, directly influence and promote NPC differentiation by stabilising protein levels of Neurog2 via direct binding and the regulation of both interkinetic and radial migration (35, 38, 39) . The transcriptome analysis of Dmrta2 -/-NPCs identified an enrichment of downregulated transcripts associated with gene ontology terms for cell adhesion (GO:0007155) and locomotion (GO:004001). It is therefore possible that defective migration is a cellular phenotype associated with the loss of Dmrta2 that could potentially lead to increased neuronal differentiation. Similarly, our RNAseq data alludes to a potential switch in the mode of cell division of Dmrta2 -/-NPCs. The transcription factors Emx2 and Pax6 were found to be downregulated and upregulated, respectively, by Dmrta2 -/-NPCs, as well as in the brains of Dmrta2-null mice (12) . Further to their roles in telencephalic patterning, Emx2 is known to promote symmetric proliferative division of NPCs and Pax6 asymmetric differentiative division (40, 41) . Thus, a switch in the mode of proliferation to neurogenic divisions may be a further cellular feature contributing to increased differentiation in the absence of Dmrta2. This is supported by the strong upregulation of mRNA transcripts for Btg2 which is exclusively expressed in cortical NPCs committed to undergoing neurogenic but not proliferative divisions (42) . Thus, while we provide evidence that Dmrta2 safeguards NPCs from precocious neurogenesis via regulation of Hes1, other targets may also contribute to the fine control of neurogenesis by Dmrta2.
Dmrta2 targets and neurogenesis
To date, Hes1 and Cdkn2c are the only two transcriptional targets proposed for Dmrta2. Due to high levels of conservation in DNA binding motifs between Dmrt proteins, further insight may be provided by examining DNA binding sites of related Dmrt family members in other tissues (31) . Close to 1,400 direct binding sites for Dmrt1 in the mouse testis have been identified using ChIP-chip techniques (43) . Many of these genes were also identified as dysregulated by our Dmrta2 -/-NPC transcriptome analysis, including: Cdkn2c, Igf2r, Meis1, Hox family members and other Dmrt genes. Although Dmrt1 is not expressed by cortical NPCs, our data suggests significant overlaps in the regulatory targets of different Dmrt proteins. This is of particular interest due to the similar expression patterns of Dmrt3, Dmrta1 and Dmrta2 in the dorsal telencephalon suggesting a potential for functional redundancy (13, 24) . A similar but less severe phenotype to that seen in Dmrta2 null mutants has been observed in mice with a Dmrt3 null mutation, further supporting the idea that the two factors have overlapping function in cortical development (12) (13) (14) . In contrast, Dmrta1-null mice produce viable offspring with no overt anatomical defects in the brain (13, 44) . This implies a hierarchical structure of importance of the Dmrt proteins to cortical development. Similar to our transgenic Dmrta2 findings, forced expression of Dmrt3 or Dmrta1 in the rodent telencephalon is linked to the regulation of Neurog2 expression (24) . Further studies may reveal to what extent this functional overlap exists between Dmrt family members in the dorsal telencephalon.
The functions of the Notch target gene Hes1 in maintaining NPC self-renewal have been well characterised (6) . Notch ligands produced by newborn neurons activate notch signalling in neighbouring cells which in turn induces expression of Hes1 to repress the transcription of proneural factors and cell cycle progression regulators, thereby inhibiting neuronal differentiation (6, 36, 37) . This lateral inhibition of spontaneous neuronal differentiation by neighbouring cells favours NPC proliferation and self-renewal. However, Hes1 expression is dynamically regulated by a number of mechanisms including: a strong negative autoregulatory function, which is in turn inhibited by interactions with Id proteins (45, 46) ; the activity of other transcription factors, such as Lhx2 (47) ; and the activation of signalling pathways by growth factors and mitogens including Fgf2 and Notch (6, 48) . Under healthy conditions, these homeostatic mechanisms help maintain a NPC pool through development by regulating the expression of Hes1 and, therefore, the balance between progenitor cell self-renewal and differentiation. This study identifies Dmrta2 as a novel factor contributing to the dynamic regulation of Hes1 expression in cortical NPCs. By promoting Hes1, and thereby suppressing downstream proneural gene expression, Dmrta2 helps contribute to the maintenance of NPC self-renewal (Fig. 8A ). In the absence of Dmrta2, Hes1 levels are reduced, leading to the upregulation of proneural genes and increased neuronal differentiation (Fig. 8B) .
In summary, we have identified Dmrta2 as a modulator controlling neuronal differentiation of cortical NPCs and provided evidence that Dmrta2 exerts this function, at least in part, by direct transcriptional regulation of neurogenesis inhibitor Hes1. Thus, this work points to another layer of control mechanisms coordinating NPC maintenance and neurogenesis, and begin to elucidate how Dmrta2 loss-of-function mutations may lead to microcephaly.
Materials and Methods
Cell culture
Six mouse ESC lines were used: a Dmrta2 flox/flox control line and two Dmrta2 -/lines derived from the control line line (SI Materials and Methods), two independent doxycycline inducible Dmrta2 overexpression ESC lines and their parental lines harbouring rtTA as reported previously (9) . All ESCs were maintained under standard conditions as previously described (17) . For monolayer based cortical differentiation, ESCs were seeded at 10 000 cells/cm 2 in gelatin-coated 6 well plates and cultured in N2B27 medium. Differentiation medium was supplemented with 100 nM LDN193189, 10 µM SB431542 from days 0 to 4, 1 µM XAV939 from day 0 to 6 (all Tocris) and 1 µM cyclopamine between days 2 and 10 (Sigma-Aldrich). On day 5 or 6 of differentiation, neural progenitor cells were dissociated using Trypsin/EDTA and replated onto poly-D-lysine/laminin coated surface at a density of 50,000 cells/cm 2 for neuronal differentiation and maturation.
Transient transfections were performed using lipofectamine 3000 reagent (Thermofisher Scientific). The following vectors were used: pHes1(2.5k)-luc (Addgene) (32); pGL4.73[hRluc/SV40] (Promega); pCAG-Hes1-IP and pmaxGFP (Lonza). Accell Hes1 and non-targeting control siRNA (GE Dharmacon) were used at a concentration of 1 µM.
Mouse Lines
Emx1-cre and Dmrta2 fl/fl mouse lines were generated and maintained as previously described (14) .
Quantitative RT-PCR (qPCR)
Total RNA was extracted using Tri reagent treated with TURBO DNase. cDNA was generated using qScript cDNA synthesis kit. qPCR was performed with Mesa Green qPCR master mix with specific primers listed in Table S1 and dissociation curves were recorded to check for amplification specificity. Cq values were normalised to a minimum of two housekeeping reference genes and changes in expression calculated using the 2 -∆∆CT method (49) . Three independent experiments were performed (n=3) and each sample measured in duplicate on a CFX Connect Real Time PCR machine.
Immunocytochemistry and EdU-labelling
Cultures were fixed with 4% (w/v) paraformaldehyde and permeabilised with 0.1% (v/v) Triton X-100. Following blocking with 2% (w/v) bovine serum albumin and 5% (v/v) donkey serum, cells were incubated with primary antibodies overnight at 4°C before incubated with complementary Alexa Fluor-conjugated antibodies and counterstained with DAPI. All antibodies used are listed in SI Materials and Methods. To quantify proliferation, differentiating cultures were incubated with 5 µM EdU for 30 minutes before fixation. EdU detection was then carried out using the Click-iT EdU Alexa Fluor 488 imaging kit (Life Technologies, UK). Images were subsequently acquired using a DMI600b inverted microscope (Leica Microsystems). Manual cell counts were performed on a minimum of 10 randomly placed fields of view per stain and the mean of three separate differentiations calculated (n=3).
Embryo sections (6-8 µm) fixed overnight in 4% paraformaldehyde/PBS, dehydrated and paraffin-embedded were processed as described previously (14) . For quantification of cells expressing Tubb3, cells of the entire dorsal telencephalon at the medial level were counted (at least 2 embryos of each genotype were analysed with a quantification of 3 to 6 sections/embryo).
Cell cycle analysis by flow cytometry
NPCs were dissociated with EDTA, washed in PBS and fixed with ice-cold 70% ethanol. After washing with 1% BSA, cell samples were incubated with mouse anti-Nestin (BD Biosciences, 611659, 1 µg/ml) or mouse IgG isotype (Sigma-Aldrich, I5381, µg/ml) antibodies overnight at 4°C. Following incubation with donkey anti-mouse Alexa-Flour 647 secondary antibody (Thermofisher Scientific, A-31571, 1:1000), DNA content was labelled by incubating cells with 1 µg/ml DAPI. Stained cells were analysed on an Amnis Flowsight (Merck Millipore) under excitation from 405 nm and 642 nm lasers. IgG isotype control samples were used to set gating parameters for nestin + neural progenitor cells and DAPI staining to identify cells at different stages of the cell cycle. Samples from three individual differentiation experiments were analysed for each time point (n=3).
RNAseq
RNA was extracted and purified using the PureLink RNA Mini Kit (Thermofisher Scientific). TruSeq Stranded mRNA kit (Illumina) was used to prepare libraries from 1 µg RNA from 3 independent differentiations (n=3). 75bp paired-end sequencing was performed on a HiSeq 4000 (Illumina, USA) yielding 30 -45 million reads per sample. Reads were mapped to the mouse genome (mm10, GRCm38) using Burrows-Wheeler Aligner algorithms (50) and individual gene read counts calculated using featureCounts (51) . DeSeq2 was used to calculate differential gene expression (52) . Gene Ontology functional enrichment for biological processes was performed using DAVID (v6.8) with mus musculus genome set as background (53) . Calculated p values were adjusted for multiple testing using the Benjamini-Hochberg correction. Raw sequence data files are publically available from the NCBI Gene Expression Omnibus (GEO accession: GSE90827).
Luciferase reporter assays
Point mutations were introduced into the pHes1(2.5k)-luc firefly luciferase vector using a Quikchange II XL Site-Directed Mutagenesis kit (Agilent Technologies) and the mutagenic primers (5'3'): CAAGGTAAAGAGGATGTGTTCCTCTAATGTCTTCCGGAATT and AATTCCGGAAGACATTAGAGGAACACATCCTCTTTACCTTG for Bs1; and GAAAGTTCCTGTGGGAAAGAAAGTTTGGGAAGTTTCAC and CAAACTTTCTTTCCCACAGGAACTTTCAGCCAATGG for Bs2. Generation of mutagenized plasmids were confirmed by sanger sequencing.
For luciferase reporter assays, cells were cultured in 24-well plates and co-transfected with 290 ng/well firefly luciferase (pHes1(2.5k)-luc and it's derivatives). 10 ng/well of renilla luciferase vector (pGL4.73) was used as an internal control to normalise for transfection efficiency and 50 ng of notch intracellular domain (NICD (pCAG-NotchIC-IP) served as a positive control. Cells were harvested 24 hours post-transfection and processed using the Dual-Glo Luciferase Assay System (Promega). Luciferase activity was measured with GloMax 96 Microplate Luminometer (Promega). Triplicate readings were taken for each sample and all experiments repeated with three biological replicates (n=3).
Chromatin immunoprecipitation (ChIP)
Approximately 10 7 cells on day 8 of differentiation were used per immunoprecipitation. Protein and DNA were cross-linked with 1% formaldehyde before cell lysis. The extracted chromatin was subsequently sonicated at high power for 20 cycles of 30 seconds on/30 seconds off with a Bioruptor (Diagenode). Immunoprecipitation was performed by incubating chromatin with custom rabbit anti-Dmrta2 or rabbit IgG isotype control antibodies and Salmon Sperm DNA/Protein A Agarose Beads (Merck Millipore). Following denaturation of crosslinks, Dmrta2-bound DNA fragments were purified using the Wizard SV Gel and PCR Clean-Up System (Promega). Immunoprecipitated DNA was subsequently amplified in qPCR reactions using the primers specified in Supplementary table 1. Two immunoprecipitations, each from a separate differentiation experiment, were performed (n = 2).
Statistical Analysis
Statistical analyses were performed using IBM SPSS 20 software. Where specified, two way ANOVA tests were performed using Dmrta2 genotype status and day of differentiation as independent variables. Simple effects analysis by post-hoc Sidak's test was used to correct for separate orthogonal comparisons between groups at each time point and to identify statistical significance. For luciferase assays and siRNA knockdown experiments one way ANOVA with Tukey-HSD post-hoc tests were performed. One tailed and two-tailed Student's t-tests were used to analyse ChIP-qPCR and Hes1-transfection rescue experiments, respectively. Two way ANOVA identified overall reduced proliferation in Dmrta2 -/-NPCs, as indicated by EdU uptake (F [1, 12] =11.336, p=0.006), and an increase in the proportion of cells staining positive for Cdkn1b (F [1, 12] =20.804, p<0.001) and Cdk1nc (F [1, 12] =10.477, p=0.007). Data are presented as mean ± s.e.m. of three independent experiments. Scale bar: 100 µm. presented as mean ± s.e.m. of three transfections, each from an independent differentiation experiment; *p<0.05; two-tailed Student's t-test. (E) Monolayer cultures of Dmrta2-ESCs were exposed to doxycycline with or without non-targeting control or Hes1 siRNA from day 5. The proportion of Nestin + NPCs and Tubb3 + neurons was quantified at day 12. Data are presented as mean ± s.e.m of >20 individual fields of view; **p<0.05; one way ANOVA with Tukey-HSD post-hoc test. 
Figure legends
SI Materials and Methods
Generation of Dmrta2 -/and Dmrta2 flox/flox mESCs The Dmrta2 gene was targeted by homologous recombination using a Dmrta2 targeting construct containing 5' and 3' arms for homologous recombination, a CMVhygrotkpA cassette flanked by two FRT sites for selection and subsequent removal of the selection cassette by flippase (Flp), exon 2 (E2) flanked by two loxP sites for Cre-mediated conditional knockout, and a Lox2272 site for facilitating exchange of reporters to the Dmrta2 locus ( Fig  S3A) . Targeting was screened by southern blots for homologous recombination (Fig. S3B) . In order to target the second Dmrta2 allele, the CMVhygrotkpA cassette was removed from the first targeted Dmrta2 mut allele by transfection with Flp construct to result in Dmrta2 flox . The Dmrta2 flox allele was distinguished from wildtype Dmrta2 by PCR genotyping using forward primer Dmrta2-KO7-p3f and reverse primer Dmrta2-KO7-p1r ( Fig. S3C and Table S1 ). After targeting of the second Dmrta2 allele, Dmrta2 flox/mut mESCs were transfected with Flp construct to remove CMVhygrotkpA cassette from the second allele to generate control Dmrta2 flox/flox mESCs. To generate Dmrta2 null ES cells (Dmrta2 -/-), Dmrta2 flox/mut cells were co-transfected with both Flp and Cre constructs to simultaneously remove CMVhygrotkpA cassette.
ESC differentiation
To differentiate ESCs towards a ventral telencephalic fate cells were seeded at 10 000 cells/cm 2 in gelatin-coated 6 well plates and cultured in N2B27 medium. Differentiation medium was supplemented with 100 nM LDN193189, 10 µM SB431542 from days 0 to 4, 1 µM XAV939 from day 0 to 6, and 1 µg/ml SHH and 10nM SAG (all Tocris) between days 2 and 10 (Sigma-Aldrich). To obtain a more caudal phenotype ESCs were seeded at 10 000 cells/cm 2 in gelatin-coated 6 well plates and cultured in N2B27 supplemented with 100 nM LDN193189 and 10 µM SB431542 from days 0 to 4. Between days 2 and 6 of differentiation N2B27 prepared with B27 supplement containing vitamin A was used. ESCs were differentiated towards a ventral midbrain fate as described previously (23) . Briefly, ESCs were seeded at 2 500 cells/cm 2 in gelatin-coated 6 well plates and cultured in N2B27 medium. Differentiation medium was supplemented with PD0325901 from day 2 to 4 and 100 ng/ml SHH, 1 µM Purmorphamine (all Tocris) and 100 ng/ml Fgf-8 between days 7 and 11. On day 5 of differentiation neural progenitor cells were dissociated using Trypsin/EDTA and replated onto poly-D-lysine/laminin coated surface at a density of 50,000 cells/cm 2 for neuronal differentiation and maturation.
Primary antibodies
The primary antibodies used are: rat anti-Bcl11b (Abcam, ab18465, 1:500), mouse anti-Coup-TF1 (Perseus Proteomics, PP-H8132-00, 1:200), custom rabbit anti-Dmrta2 (1:2000) , custom guinea pig anti-Dmrta2 (1:2000) , rabbit anti-Eomes (Abcam, ab23345, 1:500), mouse anti-FORSE-1 (Developmental Studies Hybridoma Bank (DSHB, 1:500), goat anti-FoxA2 (Santa Cruz, sc6554, 1:100), mouse anti-Gad65/67 (Merck Millipore, Mab5406, 1:500), mouse anti-GFP (Thermofisher Scientific, A11120, 1:200), rabbit anti-Ki67 (Novocastro, NCL-Ki67p, 1:500), mouse anti-Lim1 (DSHB, 1:10), custom guinea pig anti-Lmx1a (1:1000), rabbit anti-Musashi1 (Merck Millipore, AB5977, 1:200), chicken anti-Nestin (Neuromics, CH23001, 1:500), mouse anti-NeuN (Merck Millipore, MAB377, 1:400), rabbit anti-Nkx2.1 (Abcam, ab40880, 1:1000), rabbit anti-Nurr1 (Santa Cruz, sc990, 1:200), goat anti-Olig2 (R&D Systems, AF2418, 1:200), goat anti-Otx2 (Santa Cruz, sc30659, 1:100), mouse anti-Pax6 (DSHB, 1:1000), rabbit anti-p27 kip1 (Santa Cruz, sc528, 1:200), rabbit anti-p57 kip2 (Abcam, ab4058, 1:250), mouse anti-SatB2 (Abcam, ab51502, 1:10), rabbit anti-Tbr1 (Abcam, ab31940, 1:1000), sheep anti-Tyrosine Hydroxylase (Pel-Freez, P60101/1, 1:500), rabbit anti-TUBB3 (Covance, PRB-435p, 1:1000), rabbit anti-Tubb3 (Sigma, T2200, 1:200) and mouse anti-vGlut1 (Merck Millipore, MAB5502, 1:500). 
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